BIOLINK LIFE SCIENCES, INC.

Patent Applications and Registrations

Patent applications and USPTO patent grants for BIOLINK LIFE SCIENCES, INC..The latest application filed is for "liquid concentrates of calcium and magnesium".

Company Profile

0.12.10

BIOLINK LIFE SCIENCES, INC. - Cary NC US
Biolink Life Sciences, Inc - Cary NC
BioLink Life Sciences, Inc. -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Liquid Concentrates Of Calcium And Magnesium App 20220175828 - Nelson; Deanna J.	2022-06-09
Phosphorus binder composition for treatment of hyperphosphatemia Grant 8,759,398 - Nelson June 24, 2	2014-06-24
Phosphorus Binder Composition For Treatment Of Hyperphosphatemia App 20130296433 - Nelson; Deanna J.	2013-11-07
Method And Compositions For Enhancing The Safety Of Orally Administered Magnesium Alpha-lipoate App 20130296390 - Nelson; Deanna J.	2013-11-07
Combined calcium, magnesium and vitamin D supplements Grant 8,324,191 - Nelson , et al. December 4, 2	2012-12-04
Stable, Water-insoluble R-(+)-alpha-lipoic Acid Salt Useful For The Treatment Of Diabetes Mellitus And Its Co-morbidities App 20120283320 - Nelson; Deanna J.	2012-11-08
Stable, water-insoluble R-(+)-.alpha.-lipoic acid salt useful for the treatment of diabetes mellitus and its co-morbidities Grant 8,222,432 - Nelson July 17, 2	2012-07-17
Iron preparation suitable for pharmaceutical formulation and process for the preparation thereof Grant 8,178,709 - Nelson , et al. May 15, 2	2012-05-15
Phosphorus Binder Composition For Treatment Of Hyperphosphatemia App 20110269837 - Nelson; Deanna J.	2011-11-03
Phosphorus binder for treatment of renal disease Grant 8,034,833 - Nelson October 11, 2	2011-10-11
Stable, Water-insoluble R-(+)-alpha-lipoic Acid Salt Useful For The Treatment Of Diabetes Mellitus And Its Co-morbidities App 20110213022 - Nelson; Deanna J.	2011-09-01
Phosphorous Binder For Treatment Of Kidney Disease App 20110098347 - Nelson; Deanna Jean	2011-04-28
Phosphorus binder for treatment of kidney disease Grant 7,862,836 - Nelson January 4, 2	2011-01-04
Methods for the preparation, formulation and use of lithium valproate Grant 7,790,921 - Malkar , et al. September 7, 2	2010-09-07
Phosphorus binder for treatment of renal disease App 20090239914 - Nelson; Deanna Jean	2009-09-24
Non-hygroscopic L-carnitine salts Grant 7,572,832 - Malkar , et al. August 11, 2	2009-08-11
Methods for the preparation and formulation of magnesium valproate hydrate Grant 7,482,486 - Nelson , et al. January 27, 2	2009-01-27
Methods for the preparation and formulation of l-carnitine valproate salts Grant 7,456,216 - Nelson , et al. November 25, 2	2008-11-25
Methods for the preparation, formulation and use of lithium valproate Grant 7,449,598 - Malkar , et al. November 11, 2	2008-11-11
Methods for the preparation, formulation and use of lithium valproate App 20080234514 - Malkar; Navdeep B. ; et al.	2008-09-25

Company Registrations

NCAGE Code	1WR74	BIOLINK LIFE SCIENCES INC
CAGE Code	1WR74	BIOLINK LIFE SCIENCES INC
S.A.M. Registration	1WR74 [31254357]	BIOLINK LIFE SCIENCES INC

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.